DOPPL
LIVE

Serial Number

79347151

Owner

Sun bioscience SA

Attorney

Michael J. Kosma

Filing Date

May 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DOPPL Trademark

Serial Number: 79347151 • Registration: 7553975

DOPPL is a trademark filed by Sun bioscience SA on May 16, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Sun bioscience SA (2 trademarks)

Bâtiment D, EPFL Innovation Park,

Entity Type: 33

DOPPL S.A

Bâtiment D, EPFL Innovation Park,

Entity Type: 99

Trademark Details

Filing Date

May 16, 2022

Registration Date

November 5, 2024

Published for Opposition

August 20, 2024

Goods & Services

Apparatus for fermentation for laboratory use; chemistry apparatus and instruments, namely, fermentation apparatus for laboratory use for producing bioactive compounds, laboratory robots with artificial intelligence, laboratory robots with automated analysis pipelines, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, lockable petri dishes used in laboratory research, diagnostic apparatus for the detection of pathogens for laboratory or research use, laboratory organ-on-chip manufacturing equipment, laboratory 3D cell culture manufacturing equipment; downloadable computer software applications for calculations made for scientific analysis of chemical reactions, downloadable computer software applications for scientific analysis of chemical and biological reactions and downloadable computer software applications for consent management; diagnostic apparatus not for medical use for detection of pathogens for use in laboratory or research use ; DNA chips; laboratory trays

Pharmaceutical preparations for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; pharmaceutical products being preparations for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; chemical-pharmaceutical preparations for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; chemical preparations for medical use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; chemical preparations for pharmaceutical use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; biological preparations for medical use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; biological preparations for veterinary use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; vitamin preparations; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of microorganisms for medical or veterinary use; preparations being cultures of microorganisms for medical and veterinary use; bacterial culture preparations for medical or veterinary use; bacteriological culture preparations for medical or veterinary use; diagnostic preparations in the nature of biomarking reagents for medical use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; enzyme food supplements; enzyme preparations for medical use; enzyme preparations for veterinary use; enzymes for medical use; enzymes for veterinary use; immunostimulants; medicinal drinks; medicines for human use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders, remedies being medications for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders for human use; medicines for veterinary use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders, remedies being medicines for veterinary use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; nutraceutical preparations for therapeutic or medical use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; nutritive substances being nutritional supplements for microorganisms; nutritional supplements; opotherapy products being medicinal preparations for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; protein food supplements; protein supplements for animals; stem cells for medical use; stem cells for veterinary use; preparations of trace elements for human and animal consumption being nutritional supplements

Chemical substances being preparations for preserving foodstuffs; chemical preparations for scientific use other than for medical or veterinary use; chemical products being preparations for scientific analyses in laboratories other than for medical or veterinary use; chemical reagents other than for medical or veterinary use; biological preparations for use in science and industry other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; bacteriological preparations being biological preparations for use in science and industry and other than for medical or veterinary use; bacterial preparations being biological preparations for use in science and industry and other than for medical or veterinary use; bacteriological preparations being biological preparations for use in science and industry for acetification; vitamins for the food industry; vitamins for use in the manufacture of food supplements; vitamins for use in the manufacturing pharmaceutical products; vitamins for use in the manufacturing cosmetics; antioxidants used during manufacturing operations; antioxidants for use in the manufacture of cosmetics; antioxidants for use in the manufacture of food supplements; antioxidants for use in the manufacture of pharmaceutical products; enzyme preparations for industrial use; enzyme preparations for the food industry; enzymes for the food industry

Intellectual property licensing

Medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes being the treatment of persons and animals; medical screening; human tissue bank services; telemedicine services

Medical apparatus and instruments for use in preventing and treating cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; diagnostic apparatus for medical use for analysis and detection of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease; genetic disorders testing apparatus for medical use; blood testing apparatus; body composition monitors; body fat monitors; physical rehabilitation apparatus for medical use; surgical implants comprised of artificial materials; DNA and RNA testing apparatus for medical use; apparatus for the regeneration of stem cells for medical use

Scientific research; scientific research services for medical purposes; scientific laboratory services; Software as a Service (SaaS) services featuring software for calculations made for scientific analysis of chemical reactions; computer Platform as a Service (PaaS) services featuring software for calculations made for scientific analysis of chemical reactions; medical and scientific research in bacteriology; biological research; chemical analysis; chemical research; chemistry services, namely, chemical analysis and research for others; medical and scientific research, namely, conducting clinical trials for others

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 13, 2025 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Apr 4, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 4, 2025 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 17, 2024 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 5, 2024 OPNX
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 22, 2024 GNFN
FINAL REFUSAL E-MAILED
Jan 22, 2024 GNFR
FINAL REFUSAL WRITTEN
Jan 22, 2024 CNFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 17, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 17, 2024 OPNR
ASSIGNED TO EXAMINER
Dec 6, 2023 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Dec 1, 2023 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2023 TROA
CHANGE OF OWNER RECEIVED FROM IB
Oct 27, 2023 CHLD
REFUSAL PROCESSED BY IB
May 24, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 13, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 12, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 16, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 11, 2022 REPR